Distinguished in Coronary Heart Disease

Takuya Hashimoto

Hamamatsu, JP 
Distinguished in Coronary Heart Disease
Hamamatsu, JP 
OverviewLocationsClinical Research

Overview

Takuya Hashimoto practices in Hamamatsu, Japan. Mr. Hashimoto is rated as a Distinguished expert by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Arteriovenous Malformation, Ventricular Fibrillation, Percutaneous Coronary Intervention (PCI), and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 164 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 24 articles in the study of Coronary Heart Disease.

Gender
Male

Locations

Hamamatsu, 4313192, Japan
Other Locations
Inage, 2638522, Japan
Sagamihara, Japan
Kawagoe, Japan
Wako, 3510198, Japan
Toyonaka, 5608531, Japan
Tsukuba, 3058566, Japan
Chuo, Japan
Setagaya, 1568550, Japan
Tokyo, Japan
Kawasaki, 2108681, Japan
Aomi, 1350064, Japan
Saitama, Japan
Nishinomiya-hama, Japan
Osaka University 1-3 Machikaneyama Toyonaka Osaka 560-8531 Japan, Osaka, 5608531, Japan
Sakai, 5998531, Japan
Sakai, Japan
9108505, Japan
Kyoto, Japan
Chiyoda, 1018643, Japan
Mitaka, 1818588, Japan
Meguro, 1528551, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Single Continuous Intravenous Injection, Dose Escalation, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of M201-A in Healthy Japanese Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single Continuous Intravenous Injection, Dose Escalation, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of M201-A in Healthy Japanese Subjects
Enrollment Status: Completed
Publish Date: November 30, 2021
Intervention Type: Drug
Study Phase: Phase 1

164 Total Publications

Pre-pregnancy body mass index and neonatal body weight in Japanese women with gestational diabetes mellitus: Hamamatsu GRACE Study 1.
Pre-pregnancy body mass index and neonatal body weight in Japanese women with gestational diabetes mellitus: Hamamatsu GRACE Study 1.
Journal: Endocrine journal
Published: January 18, 2026

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hashimoto's expertise for a condition
ConditionClose
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile